Drug Trial Radar · NCT06041438
A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood
Last checked: Nov 20, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Sep 29, 2023
Primary completion
Nov 10, 2023
Study completion Nov 10, 2023
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Sep 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).
Conditions
- Healthy
Interventions
BI 1584862Drug
One dose with 240 mL of water after an overnight fast of at least 10 h
ItraconazoleDrug
200 mg daily after an overnight fast of at least 9 h for several consecutive days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration-time Curve of BI 1584862 in Plasma Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞)Time frame: Within 3 to 4 h before and up to 3 days after BI 1584862 administration.
- Maximum Measured Concentration of BI 1584862 in Plasma (Cmax)Time frame: Within 3 to 4 h before and up to 3 days after BI 1584862 administration.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Humanpharmakologisches Zentrum Biberach
Biberach, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.